EN
Türkçe
Deutsch
Français
Español
Português
Русский
العربية
中文
日本語
CSL Limited (CSL.AX)
CSL Limited last traded at 195.89 AUD. Over the past month the price moved +7.69%. Historical scenarios, expert targets and the plain-language read from AIsier.
One-year price chart
Last price
195.89 AUD
- 1 week
- -0.10%
- 1 month
- +7.69%
- 3 months
- +55.11%
- 1 year
- +13.01%
- 52-week high
- 196.78 AUD
- 52-week low
- 91.06 AUD
Stocks
- Symbol
- CSL.AX
- Currency
- AUD
- Sector
- Healthcare
- Market value (USD)
- 66,432,004,745 USD ()
AIsier's plain-language read
CSL's price has run up roughly a third above its longer-term average, the widest gap in a while.
What is going on right now?
The share price has climbed unusually fast lately, sitting well above where it traded over the past several months. At the same time, trading activity has been quiet, with recent daily volume at about a third of its usual pace.
How is the business itself doing?
CSL makes blood-plasma therapies and vaccines, earning about half of every sales dollar before production costs. Revenue grew around 5.5%, though the company posted a net loss this period, with profits coming in negative.
What stands out?
Despite that loss, CSL generates strong cash from operations, around A$1.89 billion. It also pays out roughly 45% of earnings as dividends.
What comes next?
Reports of a broader Australian market pullback and a slowing Chinese economy have surfaced. CSL's direct exposure to those is limited, but its next earnings update will show whether plasma demand held steady.
Historical scenarios that name this asset
FAQ
What is the current price of CSL Limited?
As of Oct. 28, 2026, the latest recorded price of CSL Limited (CSL.AX) was 195.89 AUD.
How has CSL Limited moved recently?
Measured from closing prices: -0.10% over one week, +7.69% over one month and +13.01% over one year.
Which historical scenarios name CSL Limited?
CSL Limited appears in 1 documented scenario: Australia's Market & Economic Decisions.